News|Articles|December 20, 2024
Molecular Properties of PROTACs and the Relationship to Formulation Design
Author(s)Bend BioScience
Analyzation of a diverse set of PROTAC (Proteolysis Targeting Chimeras – a class of TPDs) structures and their calculated properties, identifying key structure-property trends that contribute to low oral bioavailability.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Momentum and Automation Driving Pharma Innovation and Digitalization Through 2026
2
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
3
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
4
Johnson & Johnson’s Tecvayli Combo Wins FDA National Priority Voucher
5